BridgeBio Oncology Therapeutics, Inc. (BBOT) — Institutional Holders, Q2 2026

66 institutional investment managers reported a BBOT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $450.6M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

BBOT in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

17

Added to

21

Trimmed

14

Sold out

17

Biggest buyers

  1. VANGUARD CAPITAL MANAGEMENTAdded · +1,467,208 sh+$11.2M
  2. STATE STREETAdded · +810,291 sh+$6.2M
  3. Opaleye ManagementAdded · +646,718 sh+$4.9M
  4. SPHERA FUNDS MANAGEMENT LTD.New · +460,985 sh+$3.5M
  5. ARMISTICE CAPITALAdded · +436,000 sh+$3.3M

Biggest sellers

  1. Paradigm Biocapital AdvisorsSold out · -868,213 sh-$6.6M
  2. Octagon Capital AdvisorsSold out · -719,000 sh-$5.5M
  3. EVENTIDE ASSET MANAGEMENTSold out · -541,181 sh-$4.1M
  4. Ikarian CapitalSold out · -270,231 sh-$2.1M
  5. ROYCE & ASSOCIATESTrimmed · -251,581 sh-$1.9M

BBOT 13F holders ranked 1–66 of 66

Institutional investors reporting a position in BridgeBio Oncology Therapeutics, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Cormorant Asset Management#1 · 17,878,594 sh$136.2M0.0%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#2 · 4,885,446 sh$37.2M0.0%
Omega Fund Management#3 · 3,289,661 sh$25.1M0.0%
EcoR1 Capital#4 · 2,823,126 sh$21.5M0.0%
Alphabet#5 · 2,823,126 sh$21.5M0.0%
WELLINGTON MANAGEMENT GROUP LLP#6 · 2,789,302 sh$21.3M-1.0%
Enavate Sciences GP#7 · 2,626,946 sh$20.0M0.0%
CITADEL ADVISORS#8 · 2,617,827 sh$19.9M+3.5%
Novo A/S#9 · 2,250,000 sh$17.1M+2.9%
BlackRock#10 · 2,154,040 sh$16.4M+3.1%
VANGUARD CAPITAL MANAGEMENT#11 · 2,005,649 sh$15.3M+272.5%
Laurion Capital Management#12 · 2,002,701 sh$15.3M+4.2%
ARMISTICE CAPITAL#13 · 1,764,000 sh$13.4M+32.8%
STATE STREET#14 · 1,036,569 sh$7.9M+358.1%
Aisling Capital Management#15 · 1,018,018 sh$7.8M0.0%
Opaleye Management#16 · 700,000 sh$5.3M+1213.8%
GEODE CAPITAL MANAGEMENT#17 · 622,351 sh$4.7M+7.4%
Granahan Investment Management#18 · 558,526 sh$4.3M+141.7%
SPHERA FUNDS MANAGEMENT LTD.#19 · 460,985 sh$3.5MNew
ADAGE CAPITAL PARTNERS GP, L.L.C.#20 · 400,000 sh$3.0M0.0%
ROYCE & ASSOCIATES#21 · 384,941 sh$2.9M-39.5%
Catalio Capital Management#22 · 318,407 sh$2.4MNew
PRICE T ROWE ASSOCIATES#23 · 300,000 sh$2.3M-31.5%
VANGUARD FIDUCIARY#24 · 291,522 sh$2.2M+14.6%
CHARLES SCHWAB INVESTMENT MANAGEMENT#25 · 286,518 sh$2.2M-1.5%
Casdin Capital#26 · 282,312 sh$2.2M0.0%
Ensign Peak Advisors#27 · 273,530 sh$2.1M-14.8%
SCHRODER INVESTMENT MANAGEMENT GROUP#28 · 244,441 sh$1.9M-1.9%
FMR#29 · 240,587 sh$1.8M+0.1%
BNP PARIBAS FINANCIAL MARKETS#30 · 191,152 sh$1.5M+110.5%
NORTHERN#31 · 186,482 sh$1.4M+82.4%
Sio Capital Management#32 · 130,628 sh$995.4K0.0%
UBS Group AG#33 · 114,655 sh$873.7K+127.3%
MILLENNIUM MANAGEMENT#34 · 105,480 sh$803.8K-60.3%
GOLDMAN SACHS GROUP#35 · 102,085 sh$777.9K-39.1%
MOORE CAPITAL MANAGEMENT#36 · 100,000 sh$762.0K0.0%
Toroso Investments#37 · 93,339 sh$711.2K+13.6%
TEMA ETFS#38 · 93,339 sh$711.2K+13.6%
Brevan Howard Capital Management#39 · 88,895 sh$690.7K+523.9%
Palumbo Wealth Management#40 · 85,624 sh$652.5KNew
BANK OF AMERICA#41 · 77,140 sh$587.8KNew
Jump Financial#42 · 62,000 sh$472.4KNew
RENAISSANCE TECHNOLOGIES#43 · 58,600 sh$446.5K-42.5%
Avidity Partners Management#44 · 43,853 sh$334.2K0.0%
TD ASSET MANAGEMENT#45 · 42,730 sh$325.6K-25.8%
Virtus Investment Advisers#46 · 42,220 sh$321.7KNew
MANUFACTURERS LIFE INSURANCE COMPANY, THE#47 · 27,984 sh$213.2K-21.6%
TWO SIGMA INVESTMENTS#48 · 26,485 sh$201.8KNew
Rafferty Asset Management#49 · 22,606 sh$172.3KNew
CITIGROUP#50 · 19,872 sh$151.4KNew
Squarepoint Ops#51 · 19,662 sh$149.8K-54.5%
Vanguard Global Advisers#52 · 18,163 sh$138.4K0.0%
Schonfeld Strategic Advisors#53 · 11,504 sh$87.7KNew
PROFUND ADVISORS#54 · 11,001 sh$83.8KNew
AXQ CAPITAL#55 · 10,728 sh$81.7K-38.2%
MORGAN STANLEY#56 · 3,380 sh$25.8K-92.2%
MIRAE ASSET GLOBAL ETFS Ltd.#57 · 2,626 sh$20.1KNew
BARCLAYS PLC#58 · 2,099 sh$16.0K+890.1%
Tower Research Capital (TRC)#59 · 1,696 sh$12.9KNew
NORTHWESTERN MUTUAL WEALTH MANAGEMENT#60 · 1,350 sh$10.3KNew
Rockefeller Capital Management L.P.#61 · 1,000 sh$7.6K+42.9%
Integrated Wealth Concepts#62 · 437 sh$3.3KNew
Pacer Advisors#63 · 378 sh$3.0KNew
WELLS FARGO & COMPANY#64 · 300 sh$2.3K0.0%
Quarry#65 · 197 sh$1.5KNew
Caitong International Asset Management , Ltd#66 · 37 sh$282.00+825.0%

Funds that sold out of BBOT in Q2 2026 (17)

Held BBOT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held BBOT in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
Paradigm Biocapital Advisors868,213 sh$7.8M
Octagon Capital Advisors719,000 sh$6.4M
EVENTIDE ASSET MANAGEMENT541,181 sh$4.7M
Ikarian Capital270,231 sh$2.4M
Hudson Bay Capital Management110,000 sh$984.5K
Woodline Partners103,707 sh$928.2K
BOOTHBAY FUND MANAGEMENT80,884 sh$723.9K
HighVista Strategies78,187 sh$699.8K
Qube Research & Technologies Ltd71,925 sh$643.7K
XTX Topco Ltd59,743 sh$534.7K
ExodusPoint Capital Management48,122 sh$430.7K
ACADIAN ASSET MANAGEMENT29,148 sh$260.0K
Diametric Capital16,280 sh$145.7K
Quadrature Capital Ltd13,351 sh$119.5K
Aquatic Capital Management11,793 sh$105.5K
Bellevue Group AG6,982 sh$62.5K
ROYAL BANK OF CANADA154 sh$1.0K

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.